COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 174 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q1 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $349,000 | -50.7% | 20,008 | -43.4% | 0.00% | -50.0% |
| Q1 2022 | $708,000 | +247.1% | 35,328 | +239.7% | 0.00% | +100.0% |
| Q3 2021 | $204,000 | -19.0% | 10,400 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $252,000 | +2.0% | 10,400 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $247,000 | +20.5% | 10,400 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $205,000 | +0.5% | 10,400 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $204,000 | -28.7% | 10,400 | -51.9% | 0.00% | 0.0% |
| Q2 2019 | $286,000 | +29.4% | 21,600 | +63.6% | 0.00% | 0.0% |
| Q1 2019 | $221,000 | +25.6% | 13,200 | +22.2% | 0.00% | 0.0% |
| Q4 2018 | $176,000 | -20.4% | 10,800 | -18.2% | 0.00% | 0.0% |
| Q3 2018 | $221,000 | -32.8% | 13,200 | -2.2% | 0.00% | -50.0% |
| Q2 2018 | $329,000 | -2.7% | 13,500 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $338,000 | +96.5% | 13,500 | +33.7% | 0.00% | 0.0% |
| Q1 2016 | $172,000 | – | 10,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 2,606,500 | $48,689,000 | 2.30% |
| Camber Capital Management LP | 1,050,000 | $19,614,000 | 0.67% |
| OneAscent Wealth Management LLC | 14,131 | $264,000 | 0.66% |
| Eventide Asset Management | 2,629,593 | $49,121,000 | 0.63% |
| CLARK ESTATES INC/NY | 183,800 | $3,433,000 | 0.50% |
| Values First Advisors, Inc. | 42,312 | $790,000 | 0.47% |
| RICE HALL JAMES & ASSOCIATES, LLC | 704,201 | $13,154,000 | 0.47% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 650,398 | $12,149,000 | 0.43% |
| OneAscent Financial Services LLC | 11,774 | $220,000 | 0.42% |
| Factorial Partners, LLC | 33,300 | $622,000 | 0.41% |